eamg

cholinergic receptor nicotinic alpha 2 subunit ; Rattus norvegicus







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30796753 Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis. 2019 Jun 1
2 15843529 Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. 2005 May 1 1
3 16116977 Experimental study on induction of tolerance to experimental autoimmune myasthenia gravis by immature dendritic cells. 2005 1
4 11034361 Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. 2000 Oct 1 4
5 10102528 Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression. 1999 Feb 1
6 10606626 Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. 1999 Dec 2
7 9528890 Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. 1998 Mar 5
8 9726835 Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis. 1998 Aug 14 1
9 9010275 Age- and sex-related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats. 1997 Jan 2
10 8610979 Oral tolerance in myasthenia gravis. 1996 Feb 13 1
11 8683141 Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors. 1996 Jul 1 1
12 9099937 Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). 1996 Jun 1
13 7585970 Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis. 1995 Nov 1
14 7774622 Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. 1995 May 2
15 7520837 Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. 1994 Sep 2
16 7829669 Immunomodulation of experimental autoimmune myasthenia gravis with linomide. 1994 Dec 1
17 7683442 T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. 1993 May 1
18 8258147 T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. 1993 Dec 1
19 8505410 Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. 1993 May 1
20 1436658 In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis. 1992 Aug 31 1
21 1516631 Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. 1992 Sep 1
22 1951638 The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. 1991 Nov 2
23 1988504 Paratope- and framework-related cross-reactive idiotopes on anti-acetylcholine receptor antibodies. 1991 Feb 1 1
24 3264006 Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis. 1988 6
25 3495549 Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. 1987 Jun 1
26 2938256 Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis. 1986 Apr 18 1
27 2578165 Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction? 1985 Feb 1
28 3871377 Treatment of experimental myasthenia gravis with cyclosporin A. 1985 Feb 1
29 6332854 Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates. 1984 Nov 2
30 6611231 Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis. 1984 Jul 1
31 6354071 Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. 1983 Aug 2
32 6982313 Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. 1982 Nov 3
33 7165999 Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis. 1982 Dec 1
34 73154 Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis. 1977 Dec 1
35 182896 Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. 1976 Sep 1 4
36 182897 Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. 1976 Sep 1 4
37 1085587 Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. 1976 1
38 1127382 Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. 1975 Jun 1 1